MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Rapid on-time onset and sustained improvements in motor states throughout the day following treatment with levodopa/carbidopa intestinal gel (LCIG) vs immediate-release levodopa/carbidopa oral capsules (LCIR)

R. Pahwa, J. Aldred, N. Gupta, E. Terasawa, V. Garcia Horton, D. Macaulay, P. Kandukuri, Y. Jalundhwala, Y. Bao, P. Kukreja, S. Isaacson (Kansas City, KS, USA)
Rare variants of the LRRK2 gene in the haplotype as one of the potential risk factors for endemic parkinsonism in a small isolated region in the Czech Republic

P. Kaňovský, K. Kolaříková, R. Vodička, R. Vrtěl, K. Menšíková, T. Bartoníková, M. Procházka (Olomouc, Czech Republic)
Rate of Neuromuscular Excitation during Cycling Related to Mobility in Parkinson’s Disease

R. Daniels, C. Knight (Newark, DE, USA)
Rates of Pharmacological Treatment of Neuropsychiatric Symptoms in Early Parkinson’s Disease

C. Kulick-Soper, C. Caspell-Garcia, C. Coffey, M. Picillo, D. Weintraub, N. Dahodwala (Philadelphia, PA, USA)
RBD and autonomic dysfunction in newly diagnosed Parkinson’s disease patients

G.M Riboldi, L. Pan, K. dePaiva Lopes, K. Watkins, T. Raj, U. Kang (New York, NY, USA)
Real Time Quality Control for Subjective Endpoints in Clinical Trials

Y. Peng, G. Morinan, J. O'Keeffe (London, United Kingdom)
Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of Deep Brain Stimulation for Parkinson’s Disease

G. Deuschl, R. Jain, H. Scholtes, A. Wang, S. Paschen, M. Barbe, A. Kühn, M. Pötter-Nerger, J. Volkmann, J. Vesper (Kiel, Germany)
Real-World Data on the Use of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease who are Treated with Deep Brain Stimulation: The PD-DUAL Study

J. Aldred, F. Amjad, A. Johnson, P. Kukreja, I. Malaty, S. Parashos, J. Siddiqui, M. Siddiqui, J. Zamudio, S. Thakkar (Spokane, WA, USA)
Real-World Deutetrabenazine Dosing Patterns in Patients With Huntington’s Disease or Tardive Dyskinesia

R. Ayyagari, A. Wilhelm, J. Alexander, N. Chaijale, V. Garcia-Horton, F. Devine, B. Carroll (Boston, MA, USA)
Real-World Evaluation of Patient Characteristics and Disease Management in Long-Term Valbenazine Treatment in Adults with Tardive Dyskinesia

E. Goldberg, C. Yonan, N. Longo, H. Cratty, M. Nicosia, J. Sampalis, T. Carmack, S. Siegert, A. Angelov (San Diego, CA, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z